Discovery and development of CPL207280 as new GPR40/FFA1 agonist
Mach, Mateusz, Bazydło-Guzenda, Katarzyna, Buda, Paweł, Matłoka, Mikołaj, Dzida, Radosław, Stelmach, Filip, Gałązka, Kinga, Wąsińska-Kałwa, Małgorzata, Smuga, Damian, Hołowińska, Dagmara, Dawid, Urszula, Gurba-Bryśkiewicz, Lidia, Wiśniewski, Krzysztof, Dubiel, Krzysztof, Pieczykolan, Jerzy, Wieczorek, Maciej
Published in European journal of medicinal chemistry (15.12.2021)
Published in European journal of medicinal chemistry (15.12.2021)
Get full text
Journal Article
2333-PUB: CPL207-280, a Potent and Safe GPR40 Agonist for the treatment of Type 2 Diabetes
BAZYDLO-GUZENDA, KATARZYNA, BUDA, PAWEL, KOZLOWSKA, IZABELA, MACH, MATEUSZ, TESKA-KAMINSKA, MALGORZATA, STELMACH, FILIP, WASINSKA-KALWA, MALGORZATA, GALAZKA, KINGA, DUBIEL, KRZYSZTOF K., PIECZYKOLAN, JERZY S., WIECZOREK, MACIEJ
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY
MACH, Mateusz, MAREK, Gabriela, DUBIEL, Krzysztof, PIĄTKOWSKI, Jakub, MROCZKIEWICZ, Michal, SETNER, Bartosz, ZERO, Pawel, LEMEK, Tadeusz, GALAZKA, Kinga, JUSZCZYK, Ewelina, WIECZOREK, Maciej
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent